Technical Analysis for ZYNE - Zynerba Pharmaceuticals, Inc.
|Grade||Last Price||% Change||Price Change|
ZYNE closed down 2.0 percent on Wednesday, January 16, 2019, on 63 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|Weak or Absent||Down||Down||Down|
|See historical ZYNE trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 16||NR7||Range Contraction||0.00%|
|Jan 16||Inside Day||Range Contraction||0.00%|
|Jan 16||Wide Bands||Range Expansion||0.00%|
|Jan 15||Spinning Top||Other||-2.00%|
|Jan 15||Wide Bands||Range Expansion||-2.00%|
|Jan 15||Overbought Stochastic||Strength||-2.00%|
|Jan 14||Weak + Overbought||Other||1.03%|
|Jan 14||Wide Bands||Range Expansion||1.03%|
|Jan 14||Overbought Stochastic||Strength||1.03%|
|Jan 14||Down 3 Days in a Row||Weakness||1.03%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on developing and commercializing synthetic cannabinoid therapeutics formulated for transdermal delivery. The Company has two product candidates, including ZYN002 and ZYN001, which represent cannabinoid therapeutics for several indications, including refractory epilepsy, Fragile X syndrome (FXS), osteoarthritis (OA), fibromyalgia and peripheral neuropathic pain. ZYN002 is a synthetic cannabidiol (CBD) formulated as a permeation-enhanced gel for transdermal delivery. In preclinical animal studies, ZYN002's permeation enhancer increased delivery of CBD through the layers of the skin and into the circulatory system. ZYN001 is a pro-drug of delta-9-tetrahydrocannabinol (THC) that enables transdermal delivery through a patch. In preclinical animal studies, ZYN001 demonstrated effective skin permeation with sustained delivery and rapid conversion of ZYN001 to THC.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ZYNE news...
|52 Week High||12.98|
|52 Week Low||2.75|
|200-Day Moving Average||7.6022|
|50-Day Moving Average||4.5136|
|20-Day Moving Average||3.599|
|10-Day Moving Average||4.015|
|Average True Range||0.3392|
|Chandelier Exit (Long, 3 ATRs )||3.4824|
|Chandelier Exit (Short, 3 ATRs )||3.7676|
|Upper Bollinger Band||4.5837|
|Lower Bollinger Band||2.6143|
|Percent B (%b)||0.66|
|MACD Signal Line||-0.227|
|Market Cap||51.97 Million|
|Num Shares||13.3 Million|
|Price-to-Earnings (P/E) Ratio||-1.51|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||4.18|
|Resistance 3 (R3)||4.20||4.15||4.13|
|Resistance 2 (R2)||4.15||4.08||4.13||4.12|
|Resistance 1 (R1)||4.03||4.04||4.01||4.01||4.10|
|Support 1 (S1)||3.86||3.91||3.84||3.84||3.74|
|Support 2 (S2)||3.81||3.87||3.79||3.72|
|Support 3 (S3)||3.69||3.81||3.71|
|Support 4 (S4)||3.67|